(Phys.org)—While studying a mutant strain of yeast, Purdue University researchers may have found a new target for drugs to combat cholesterol and fungal diseases.
Feb 25, 2013
4.8 / 5 (5)
0
|
Researchers have identified enzymes and biochemical compounds called lipids that are targeted and modified by the dengue virus during infection, suggesting a potential new approach to control the aggressive ...
Mar 22, 2012
5 / 5 (3)
0
|
Contrary to common perception, state and local police are often on the front lines against product counterfeiting, yet it's unclear how prepared they are to deal with the growing crime, according to a new report from two ...
Feb 22, 2012
not rated yet
0
Using a sophisticated technique of x-ray crystallography, researchers Xiaohu Mei, PhD, and David Atkinson, PhD, from Boston University School of Medicine (BUSM) have for the first time obtained an "image" of the structure ...
Nov 04, 2011
not rated yet
0
|
(PhysOrg.com) -- Scientists from Imperial College London and Diamond Light Source have revealed the structure of a cholesterol-lowering-drug target. Published in the journal Nature, this finding could lead ...
Oct 06, 2011
not rated yet
0
The US Supreme Court on Thursday allowed a class-action suit by alleged victims of the anti-cholesterol drug Baycol, which was taken off the market in 2001 by German pharmaceuticals giant Bayer.
Jun 16, 2011
not rated yet
0
In 2001, Abbott Laboratories spent nearly $7 billion on the biggest acquisition in the company's 123-year history, primarily to access one drug, Humira.
May 27, 2011
5 / 5 (1)
0
(AP) -- Disappointing news: A drug that raises people's so-called good cholesterol didn't go on to prevent heart attacks.
May 26, 2011
not rated yet
0
A protein has been discovered that may have a profound effect on cholesterol metabolism. That discovery raises the possibility that the protein, dubbed IDOL, could be a powerful target for cholesterol-lowering drugs, says ...
May 17, 2011
not rated yet
0
A needle-in-the-haystack search through nearly 390,000 chemical compounds had led scientists to a substance that can sneak through the protective barrier surrounding the brain with effects promising for new drugs for Parkinson's ...
Apr 20, 2011
5 / 5 (1)
0
(PhysOrg.com) -- New research has shown that a federally approved pharmaceutical for treating periodontal disease also significantly reduces risk of osteoporosis and cardiovascular disease in postmenopausal ...
Mar 10, 2011
5 / 5 (2)
0
(PhysOrg.com) -- A combination drug that lowers levels of 'bad' cholesterol in the blood can benefit people with chronic kidney disease and is safe, a study led by the Clinical Trial Service Unit at Oxford University has ...
Nov 22, 2010
not rated yet
0
Higher doses of statins cut the risk of heart attacks and stroke by one-seventh compared with regular statin treatment, according to a review published online on Tuesday by The Lancet.
Nov 08, 2010
not rated yet
1
Different formulations of red yeast rice, a supplement marketed as a way to improve cholesterol levels, appear widely inconsistent in the amounts of active ingredients they contain, according to a report in the October 25 ...
Oct 25, 2010
5 / 5 (2)
1
(AP) -- Pfizer Inc. said Tuesday it will buy a company specializing in pain drugs in a $3.6 billion deal meant to shore up the portfolio of the world's largest drug company.
Oct 12, 2010
not rated yet
0
